CIK 0001698530 · Non-accelerated filer<br>Smaller reporting company
EXICURE, INC.
Sign in to watch- Ticker
- XCUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 815333008
- Phone
- 847-673-1707
- Business address
- 2430 N. HALSTED ST., CHICAGO, IL, 60614
- Former names
- Max-1 Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 9 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-16 | Miller Josh Chief Accounting Officer | Shares withheld for taxes | −38 | $0.57 | $21 | 1,873 |
| 2023-08-16 | Miller Josh Chief Accounting Officer | Shares withheld for taxes | −37 | $0.83 | $31 | 1,911 |
| 2023-06-23 | CBI USA, Inc. 10% owner | Conversion | −3,400,000 | $1.60 | $5.4M | 818,299 |
| 2023-06-23 | CBI USA, Inc. 10% owner | Conversion · CBI USA, Inc. 1st Bearer-type Interest Unsecured Private | −0 | 0 | ||
| 2023-05-16 | Miller Josh Chief Accounting Officer | Shares withheld for taxes | −185 | $1.07 | $198 | 1,948 |
| 2023-02-22 | CBI USA, Inc. 10% owner | Other disposition · CBI USA, Inc. 1st Bearer-type Interest Unsecured Private | −5,440,000 | $5,440,000.00 | $29593.6B | 5,440,000 |
| 2023-01-04 | Hwang Jiyoung Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2022-12-15 | CBI USA, Inc. 10% owner | Purchase | +3,400,000 | $1.60 | $5.4M | 4,218,299 |
| 2022-06-13 | GAROFALO ELIZABETH A. Director | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-06-13 | SULAT JAMES R Director | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-06-13 | Cleland Jeffrey L Director | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-06-13 | Muralidhar Bali Director | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-05-19 | Muralidhar Bali Director | Purchase | +1,472,126 | $0.19 | $285K | 8,449,126 |
| 2022-05-16 | Longoria Sarah Chief HR & Compliance Officer | Grant or award · Employee Stock Option (right to buy) | +180,750 | 180,750 | ||
| 2022-05-16 | SCHROFF MATTHIAS Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +2,324,550 | 2,324,550 | ||
| 2022-05-16 | Papadimas Elias D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +424,000 | 424,000 | ||
| 2021-12-21 | Gates Frontier, LLC 10% owner | Sale | −1,268,619 | $0.24 | $303K | 5,064,703 |
| 2021-11-15 | Giljohann David A Chief Executive Officer | Grant or award | +7,500 | $0.91 | $7K | 38,666 |
| 2021-11-15 | Feltner Douglas E. Chief Medical Officer | Grant or award | +7,500 | $0.91 | $7K | 15,000 |
| 2021-08-27 | Papadimas Elias D. Chief Accounting Officer | Purchase | +10,000 | $1.38 | $14K | 10,000 |
Page 2 of 7 · 122 trades